Wednesday, November 18, 2026

NEUROINFLAMMATION IN GLAUCOMA (PART 3)

 


Complement activation constitutes another key early inflammatory event in glaucoma. The complement system represents a central component of the innate neuroimmune response. Neuroimmune activation is not only confined to the eye: glial reactivity has been demonstrated along the retrobulbar optic nerve and in central visual structures, including the lateral geniculate nucleus, superior colliculus, and visual cortex.

In glaucoma, the classical pathway appears particularly relevant to early synaptic and dendritic injury. Elevated complement levels are detected in glaucomatous retinas, particularly at the optic nerve head (ONH) and inner retinal layers. Activation of retinal astrocytes correlates with increased C1q expression in retinal ganglion cells (RGCs). 




C1q acts as a pattern-recognition molecule that labels stressed synapses, dendrites, and damaged cellular elements for removal. C1q expression is increased in ONH microglia before overt axonal degeneration in experimental glaucoma, while C1q deposition has also been detected within RGC dendrites in experimental models, non-human primates, and human glaucomatous retinas. This reactivation of a developmental synaptic-pruning pathway may cause inappropriate microglial elimination of otherwise salvageable RGC synapses. 

In a genetic model of glaucoma, Shinozaki et al. reported that elevated IOP was accompanied by retinal C1q upregulation and RGC apoptosis. [Shinozaki Y,Kashiwagi K, Koizumi S. Astrocyte immune functions and glaucoma. Int J Mol Sci. (2023) 24:2747.]  RGCs can sense damage and activate C1, triggering a cascade that activates C3 and C5 and recruits immune cells to the injury site. In a neonatal hyperoxia model, activated microglia engulfed endothelial cell fragments during retinal vessel regression, while partial microglial depletion attenuated early vascular regression and endothelial apoptosis. [Xu, Z.; Ma, Y.; Li, J.; Zhuang, J.; Liu, Y.; Lin, Z.; Liu, B.; Zhu, Z.; Chen, Z.; Wei, X.; et al. Microglial phagocytosis involves hyperoxia-induced vessel regression in the neonatal retina. Vis. Neurosci. 2025, 42, e004.]

Importantly, the role of C3 in glaucoma appears to be context dependent, showing a duality between early neuroprotection and late-stage neurotoxicity. Complement factors have dual roles in glaucoma. Early C3 activity may support protective astrocytic responses, while excessive or prolonged C3 activation and C3a receptor signaling can promote microglial recruitment and optic nerve degeneration. 




Membrane attack complexes (MACs) accumulate in the ONH and RGCs, and MAC inhibition reduces RGC apoptosis. Recent evidence suggests that in the early phase of disease, astrocyte-derived C3 can signal through the epidermal growth factor receptor (EGFR) pathway, promoting astrocytic survival responses and metabolic support to stressed axons. This transient EGFR–C3 interaction may act as a compensatory mechanism, particularly under acute intraocular pressure (IOP) elevation, to preserve tissue integrity. Formation of C5b–9 may directly injure RGCs through membrane lysis; even at sublytic concentrations, MAC can stimulate intracellular Ca2+ signaling and further inflammatory activation. Increased deposition of C1q, C3, C5, and MAC has been reported in experimental and human glaucoma, including C5b–9 deposition on RGCs.

However, with sustained or chronic activation, persistent C3 cleavage leads to excessive production of downstream complement fragments (C3b, C5b-9) and ultimately the formation of MAC. MAC deposition on RGC somas and axons contributes to neurodegeneration by inducing membrane pore formation and triggering inflammatory cell recruitment. 

Ischemia-reperfusion increases retinal complement expression and deposition, while C3 knockout reduces optic nerve damage and increases RGC survival. 

Reactive microglia and astrocytes up-regulate major histocompatibility complex molecules, cytokines, chemokines, adhesion molecules, and antigen-presentation pathways. Concurrent dysfunction of astrocytes and vascular endothelial cells may increase blood–retinal barrier permeability, thereby creating a permissive environment for peripheral immune-cell trafficking. CCL2/CCR2 chemokine axis promotes transendothelial recruitment of circulating monocytes into the ONH and retina. These monocyte-derived macrophages may amplify local inflammation in early glaucoma through additional secretion of TNF-α, IL-1β, IL-6, and complement components.

Enucleated eyes from patients with advanced glaucoma show increased IBA1 immunoreactivity, reflecting microglial or macrophage activation, together with marked GFAP-positive astrocytic and Müller-cell gliosis in the retina and ONH. These findings validate the impression that neuroinflammation plays a central role in glaucomatous neurodegeneration.



Thursday, November 12, 2026

NEUROINFLAMMATION IN GLAUCOMA (PART 2)

 


Neuroinflammation in glaucoma is best understood as a chronic, spatially organized, and self-amplifying response to neuronal and axonal stress rather than as a conventional inflammatory reaction. The optic nerve head (ONH) is a major site at which multiple stressors converge.

Mechano-sensitive signaling and intracellular Ca2+ overload promote the extracellular release of adenosine triphosphate (ATP), which has a role in inflammation, as described subsequently.

Stressed RGCs, damaged axons, and dysfunctional mitochondria release damage-associated molecular patterns (DAMPs), including heat-shock proteins (HSPs), high-mobility group box 1 (HMGB1), mitochondrial DNA, oxidized proteins, and reactive oxygen species (ROS). These signals are detected by pattern-recognition receptors expressed by microglia, astrocytes, and Müller cells, particularly toll-like receptors (TLRs) and purinergic P2X7 receptors.

Toll-like receptors (TLRs), a pivotal subset of pattern recognition receptors (PRRs), serve as sentinels of the innate immune system by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). In glaucomatous retina, TLR expression is markedly elevated. In vitro studies reveal that both HSPs and oxidative stress act as potent inducers of TLR expression, thereby amplifying the release of pro-inflammatory cytokines and immunostimulatory mediators that activate both innate and adaptive immune pathways. Notably, tenascin-C, an endogenous ligand for TLR4, is upregulated in glaucomatous ONH and has been shown to activate TLR4 signaling in arthritis. It is hypothesized that tenascin-C may initiate inflammation via TLR4 prior to DAMP release by injured RGCs.

TLR engagement activates MyD88- and TRIF-dependent signaling and the transcription factor NF-κB, whereas ATP-mediated P2X7 activation induces K+ efflux, ROS generation, and lysosomal destabilization, thereby promoting assembly of the NLRP3 inflammasome. Activated NLRP3 subsequently stimulates caspase-1-dependent maturation of IL-1β and IL-18, establishing an inflammatory feedback-loop that further increases glial activation and RGCs’ vulnerability. 

Microglia are among the earliest cellular responders to glaucomatous stress, and their activation may precede detectable RGC loss. Under physiological conditions, ramified microglia continuously survey the retinal microenvironment, remove cellular debris, regulate synaptic remodeling, and provide trophic support. During the early phases of injury, these functions may remain adaptive and contribute to tissue repair.

Persistent biomechanical, oxidative, or metabolic stress, however, induces a transition toward amoeboid, highly phagocytic, and pro-inflammatory states characterized by the release of TNF-α, IL-1β, IL-6, chemokines, nitric oxide, ROS, matrix metalloproteinases, and complement components.

Microglial signals also induce reactive changes in astrocytes and Müller cells, while astrocyte-derived mediators reciprocally regulate microglial migration, complement expression, and phagocytosis. Astrocytes can initially preserve tissue architecture, vascular-barrier integrity, metabolic support, and glutamate homeostasis; with prolonged reactivity, however, astrocytes reduce their neurotrophic and antioxidant support, remodel the extracellular matrix, and amplify inflammatory signaling through their extensive gap-junction networks.

Müller-cell dysfunction additionally impairs extracellular glutamate clearance, contributing to excitotoxicity. In this context, soluble glia-derived TNF-α provides a direct molecular link between neuroinflammation and excitotoxic RGC death by increasing the surface expression of Ca2+-permeable AMPA receptors, thereby promoting Ca2+ overload, mitochondrial dysfunction, and axonal cytoskeletal damage. These interactions can be integrated into a self-sustaining mitochondrial-neuroinflammatory closed loop.




Initial impairment of mitochondrial electron transport chain (ETC) function increases electron leakage and mitochondrial ROS production. ROS damage the mitochondrial proteins, lipids, and DNA, and promote the extracellular release of mitochondrial DNA, oxidized molecules, ATP, and other DAMPs. Recognition of these signals by microglial TLRs, P2X7 receptors, and inflammasome pathways reinforces microglial activation and the secretion of TNF-α and other inflammatory mediators.

TNF-α-driven NF-κB signaling can, in turn, impair mitochondrial biogenesis and respiratory-chain homeostasis, including reduced expression or function of ETC subunits, thereby worsening electron leakage, ATP failure, and ROS generation. The newly generated ROS and DAMPs re-enter the same pathway, converting an initially trigger-dependent response into a feed-forward cycle of mitochondrial failure and glial activation.


Glial activation & immune crosstalk in glaucoma


Once sufficiently established, this loop may persist after the initiating mechanical or ischemic stress has diminished and may become partly independent of external IOP. 

It therefore provides a mechanistic explanation for continuing degeneration in NTG and in patients who progress despite achieving target IOP, although the relative contribution of each link and the point at which the loop becomes autonomous remain to be established in human glaucoma.





Saturday, November 7, 2026

NEUROINFLAMMATION IN GLAUCOMA (PART 1)

 




Glaucoma is being increasingly recognized as a multifactorial neurodegenerative optic neuropathy in which intraocular pressure (IOP) is one of several stress amplifiers rather than a sole etiological factor.

IOP exposure interacts with, but does not fully account for vascular dysregulation, impaired ocular perfusion, mitochondrial susceptibility, metabolic failure, oxidative stress, excitotoxicity, and neuroimmune dysregulation, seen as part of glaucomatous neural degeneration.

However, IOP-related mechanical and ischemic stress can disrupt axonal transport and amplify these processes, increasing reactive oxygen species (ROS) and the release of damage-associated molecular patterns (DAMPs) that activate innate immune pathways.

Resident glia respond to these stress signals by releasing cytokines, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6), which affect retinal ganglion cell (RGC) somas, axons, and synapses.

Within this inflammatory milieu, synaptic structures are particularly vulnerable. Proinflammatory cytokines, together with complement cascade activation, drive synapse elimination, dendritic remodelling, and early functional disconnection of RGCs from their central targets. This synaptic dysfunction represents a critical initiating step in anterograde trans-synaptic degeneration, through which pathological signals propagate from the retina to second- and third-order neurons in the lateral geniculate nucleus (LGN) and visual cortex.

At the same time, retrograde signaling mechanisms further contribute to neuronal loss, highlighting the bidirectional nature of degeneration along the visual pathway.

Importantly, neuroinflammation is not confined to the site of initial injury but spreads across synaptically connected regions, where activated microglia and infiltrating immune cells perpetuate cytokine production and sustain chronic inflammation.

Additional mechanisms, including activation of intrinsic axonal degeneration pathways such as SARM1 and impaired neurotrophic support, further facilitate the propagation of damage across neuronal networks.

Collectively, these findings support a multifactorial stress-amplification model that links local retinal injury to central visual-pathway degeneration.

This concept is particularly relevant to normal-tension glaucoma (NTG), which represents a large proportion of primary open-angle glaucoma in Asian populations, and to patients who continue to progress despite IOP being maintained within the target range.





Sunday, November 1, 2026

AI-BASED ESTIMATION OF TIA FROM SLITLAMP IMAGES



Mizukami and colleagues from Japan have developed an artificial intelligence (AI) model for quantitative trabecular–iris angle (TIA) estimation from anterior-segment images acquired with a smartphone-attached to the slit-lamp microscope.

Narrowing of the TIA is a key anatomical feature of primary angle-closure disease and contributes to impaired aqueous humor outflow.




Eyes with crowded anterior segments characterized by shallow anterior chamber depth (ACD), thicker crystalline lenses, or an anteriorly positioned lens have reduced angular width between the iris and trabecular meshwork, predisposing them to angle closure.

In Primary Angle Closure Suspect (PACS), an occludable narrow angle, defined by at least 180° of iridotrabecular contact observed on gonioscopy, is present without elevation of intraocular pressure or evidence of optic nerve damage. Later, primary angle closure glaucoma (PACG) can develop, with optic nerve head changes, such as cupping.

Traditional methods for detecting narrow angles and angle-closure disease have significant limitations in accessibility and scalability.

Gonioscopy is inherently subjective, requiring specialized skills and proper technique, which results in notoriously low adoption rates in general clinical practice and large-scale screening programs.

Other methods such as Van Herick, and anterior segment OCT (AS-OCT) have issues of sensitivity and cost factors with specialized equipment, with respect to the latter.

AI, particularly deep learning, has emerged as a highly effective tool in medical image analysis, including ophthalmology.

Videos were acquired with a slitlamp attached smartphone using direct focal illumination, a 0.1~0.3 mm full-height slit beam angled at 40°, and were required to show both the cornea and crystalline lens in focus for at least five seconds.

Corresponding TIA measurements were obtained by AS-OCT under standardized lighting. The SEC and AS-OCT examinations were performed during the same clinical session.

After the general diagnosability filtering and patient-level dataset partitioning, frame eligibility was assessed separately for each anatomical direction.

This was followed by training a deep learning model on AS-OCT-derived parameters obtained from smartphone images, thereby facilitating the collection of large volumes of standardized data.

A paired dataset comprising slit-lamp videos and corresponding AS-OCT measurements from 2654 eyes and a ResNet50-based deep-learning model to estimate TIA500 was developed.

The predicted values showed moderate correlations and good agreement with the AS-OCT measurements.

Given the moderate correlations and observed prediction errors, the current model should be regarded as a proof-of-concept rather than a substitute for gonioscopy or AS-OCT, particularly because prediction errors may affect the classification of eyes near clinically relevant narrow-angle thresholds. Further model improvement and external validation across different populations, institutions, and imaging devices are required before its utility in clinical decision-making or population screening can be established.

REFERENCE:

Shimizu E, Tanaka K, Nishimura H, Agata N, Tanji M, Nakayama S, Khemlani RJ, Yokoiwa R, Sato S, Shiba D, Sato Y. The Use of Artificial Intelligence for Estimating Anterior Chamber Depth from Slit-Lamp Images Developed Using Anterior-Segment Optical Coherence Tomography. Bioengineering (Basel). 2024 Oct 9;11(10):1005. doi: 10.3390/bioengineering11101005. PMID: 39451381; PMCID: PMC11505230.



NEUROINFLAMMATION IN GLAUCOMA (PART 3)

  Complement activation constitutes another key early inflammatory event in glaucoma. The complement system represents a central component o...